Summary for ARTG Entry:
CANESTEN PLUS CLOTRIMAZOLE AND HYDROCORTISONE CREAM tube (new formulation)
ARTG entry for
Bayer Australia Ltd
PO Box 182,Gordon NSW 2072,Gordon, NSW, 2072
ARTG Start Date
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. CANESTEN PLUS CLOTRIMAZOLE AND HYDROCORTISONE CREAM tube (new formulation)
Single Medicine Product
No Warnings included on Record
For dermatophyte and yeast infections of the skin when inflammation is prominent. This includes conditions such as fungal infected intertrigo.
Additional Product information
Store below 25
Neither child resistant
closure nor restricted
Pack Size/Poison information
(S2) Pharmacy Medicine
Route of Administration
White to slightly yellowish cream
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 28.11.2017 at 09:29:25 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information